[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581597":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":30,"locations":36,"responsibleParty":59,"collaborators":10,"id":63,"slug":10,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":10,"eligibilityCriteria":68,"healthyVolunteers":64,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":10,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Ain Shams University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Iliopsoas nerve block group",null,"Patients will receive an Iliopsoas nerve block using 10 ml of bupivacaine 0.5%.",[13],"Drug: Iliopsoas nerve block",{"label":15,"type":10,"description":16,"interventionNames":17},"Femoral nerve block group","Patients will receive femoral nerve block using 10 ml of bupivacaine 0.5%.",[18],"Drug: Femoral nerve block",[20,26],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","Iliopsoas nerve block",[9],[25],"Bupivacaine 0.5%",{"type":21,"name":27,"description":16,"armGroupLabels":28,"otherNames":29},"Femoral nerve block",[15],[25],[31],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},"Hazem K Saeed, Master","CONTACT","00201016056123","hazem.khaled@med.asu.edu.eg",[37],{"facility":5,"status":38,"city":39,"state":10,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Cairo","11591","Egypt",{"type":43,"coordinates":44},"Point",[45,46],31.24967,30.06263,{"lat":46,"lon":45},[49,50,53,55,57],{"name":32,"role":33,"phone":34,"phoneExt":10,"email":35},{"name":51,"role":52,"phone":10,"phoneExt":10,"email":10},"Mohamed I Shahata, MD","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":10,"phoneExt":10,"email":10},"Adel M Al Ansary, MD",{"name":56,"role":52,"phone":10,"phoneExt":10,"email":10},"Rania H Abdelhafiez, MD",{"name":58,"role":52,"phone":10,"phoneExt":10,"email":10},"Ibrahim M El-sherif, MD",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Hazem Khaled Abdelrazek Saeed","Assistant Lecturer of Anesthesia, Intensive Care and Pain Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.","100581597",false,"NCT06852378","Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries","Comparison Between Iliopsoas Nerve Block and Femoral Nerve Block in Hip Fracture Surgeries","Inclusion Criteria:\n\n* Age from 18 to 65 years.\n* Both sexes.\n* American Society of Anesthesiologists (ASA) physical status I and II.\n* Patients who are scheduled for elective surgical correction of hip fracture either through open fracture internal fixation (ORIF), partial hip arthroplasty or total hip arthroplasty.\n\nExclusion Criteria:\n\n* Refusal to participate.\n* Coagulopathy.\n* Patients with a history of drug allergies to study drugs.\n* Inability to cooperate.","ALL","18 Years","65 Years",{"count":73,"type":74},80,"ESTIMATED","OBSERVATIONAL","This study aims to compare iliopsoas nerve Block (IPB) to femoral nerve block (FNB) regarding pain control, patient satisfaction, and early ambulation in patients undergoing hip fracture surgeries",[78,79,80],"Iliopsoas Nerve Block","Femoral Nerve Block","Hip Fracture Surgeries","2025-03-01",{"date":83,"type":84},"2025-03-04","ACTUAL",{"date":81,"type":84},{"date":87,"type":74},"2026-02-01",{"name":5,"class":6},1]